- Report
- November 2021
- 233 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- January 2023
- 256 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- March 2022
- 210 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- March 2022
- 230 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
- Book
- January 2024
- 496 Pages
- Book
- October 2020
- 288 Pages
The Digital Polymerase Chain Reaction (dPCR) market is a subset of the genomics industry. It is a technology used to detect and quantify nucleic acid molecules, such as DNA and RNA. It is a highly sensitive and specific method for detecting and quantifying nucleic acid molecules, and is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics. dPCR is also used in research and development, as well as in clinical settings.
dPCR is a cost-effective and efficient method for detecting and quantifying nucleic acid molecules, and is becoming increasingly popular in the genomics industry. It is used in a variety of applications, including gene expression analysis, genotyping, and diagnostics.
Some companies in the dPCR market include Bio-Rad, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, and Illumina. Show Less Read more